What's Happening?
The Royal Pharmaceutical Society (RPS) has published a summary of the top five articles from its research journals in 2025, marking a 25% increase in publications compared to 2024. The articles cover a wide
range of topics, including the development of new drugs for cancer and kidney disease, pharmacists' independent prescribing, and efforts to combat antimicrobial resistance. The journals also address the environmental impact of medicines and transparency in pharmaceutical health systems. The RPS journals, published in partnership with Oxford University Press, aim to advance the field of pharmacy by disseminating high-quality research and maintaining a scientific record.
Why It's Important?
The increase in research publications by the RPS reflects the growing importance of pharmacy and pharmacology in addressing global health challenges. The highlighted articles demonstrate the critical role of pharmacists in healthcare, particularly in areas like drug development and antimicrobial resistance. By focusing on sustainability and transparency, the RPS journals contribute to ongoing discussions about the ethical and environmental responsibilities of the pharmaceutical industry. This research supports the RPS's mission to position pharmacy at the forefront of patient care, influencing policy and practice in the healthcare sector.
